NIHBC 10 - CRC BG RM 1-3121
10 CENTER DR
BETHESDA MD 20892
Download CV (PDF 90 KB)
Crystal Kamilaris, M.D., is a clinician investigator in endocrine hypertension and adrenocortical disease, specializing in internal medicine and adult endocrinology. She serves as a staff clinician for NICHD as well as co-chief of the internal medicine, endocrinology, and genetics inpatient ward and outpatient endocrinology clinic, and as faculty for the NIH Inter-Institute Endocrinology Training Program (IETP). She completed her medical school training at the University of Patras School of Health Sciences in Greece. She did her residency in internal medicine at the University of Connecticut, where she completed the clinician educator track, and her fellowship training in adult endocrinology, diabetes, and metabolism in the IETP, with a clinical and research focus on endocrine hypertension, adrenocortical tumors, pituitary disease, and multiple endocrine neoplasia. She is board certified in internal medicine and endocrinology, diabetes, and metabolism by the American Board of Internal Medicine.
Since 2017, Dr. Kamilaris has worked with NICHD in the laboratory of Dr. Constantine Stratakis as an associate investigator, on several adrenal and genetic-related natural history protocols to understand the pathophysiology and genetics of adrenal and pituitary tumors, with a special focus on primary aldosteronism in African Americans including: Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks (18-CH-0031), Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue (00-CH-0160), Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome, and Related Conditions (95-CH-0059), Evaluation of Adults with Endocrine-Related Conditions (16-CH-0125), and A Clinical and Genetic Investigation of Pituitary and Hypothalamic Tumors and Related Disorders (97-CH-0076).
Mosaicism for KCNJ5 causing early-onset primary aldosteronism due to bilateral adrenocortical hyperplasia.
Maria AG(1), Suzuki M(1)(2), Berthon A, Kamilaris C(1), Demidowich A(1), Lack J(3)(4), Zilbermint M(1)(5)(6), Hannah-Shmouni F(1), Faucz FR(1), Stratakis CA(1).
Am J Hypertens. 2019 Oct 22. pii: hpz172. doi: 10.1093/ajh/hpz172. [Epub ahead of print]
Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis.
Kamilaris CDC(1), Stratakis CA(1).
Front Endocrinol (Lausanne). 2019 Jun 11;10:339. doi: 10.3389/fendo.2019.00339. eCollection 2019.
Adrenocortical tumorigenesis: Lessons from genetics.
Kamilaris CDC, Hannah-Shmouni F, Stratakis CA.
Best Pract Res Clin Endocrinol Metab. 2020;34(3):101428. doi:10.1016/j.beem.2020.101428
Kamilaris CDC(1), Faucz FR(1), Voutetakis A(2), Stratakis CA(1).
Exp Clin Endocrinol Diabetes. 2019 Feb;127(2-03):156-164. doi: 10.1055/a-0753-4943. Epub 2018 Nov 14.
Endocrine Conditions and COVID-19.
Shekhar S, Wurth R, Kamilaris CDC, et al.
Horm Metab Res. 2020;52(7):471-484. doi:10.1055/a-1172-1352